Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1996 3
1997 5
1998 25
1999 10
2000 5
2001 2
2005 1
2006 1
2007 1
2012 1
2013 1
2014 4
2015 3
2016 2
2017 4
2018 3
2019 3
2020 1
2021 3
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review.
Muskens JB, Velders FP, Staal WG. Muskens JB, et al. Eur Child Adolesc Psychiatry. 2017 Sep;26(9):1093-1103. doi: 10.1007/s00787-017-1020-0. Epub 2017 Jul 3. Eur Child Adolesc Psychiatry. 2017. PMID: 28674760 Free PMC article. Review.
The literature was searched using the PubMed and PsycINFO databases (2000-1 May 2016) with the keywords "[((child and adolescent) AND (Autism OR Attention Deficit Hyperactivity Disorder* OR ADHD)) AND ("Cardiovascular Diseases" [Mesh] OR "Endocrine System Diseases" [Mesh] OR "Imm …
The literature was searched using the PubMed and PsycINFO databases (2000-1 May 2016) with the keywords "[((child and adolescent) AND (Autis …
Statins for Smith-Lemli-Opitz syndrome.
Ballout RA, Livinski A, Fu YP, Steiner RD, Remaley AT. Ballout RA, et al. Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013521. doi: 10.1002/14651858.CD013521.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373961 Free PMC article. Review.
None of the included studies evaluated survival or reported quality of life (QoL). Only the included RCT formally assessed changes in the neurobehavioral manifestations of SLOS, and we are uncertain whether statin therapy improves this outcome (very low-certainty ev …
None of the included studies evaluated survival or reported quality of life (QoL). Only the included RCT formally assessed changes in the …
Toxic leukoencephalopathy.
Filley CM. Filley CM. Clin Neuropharmacol. 1999 Sep-Oct;22(5):249-60. Clin Neuropharmacol. 1999. PMID: 10516874 Review.
Many patients have reversible leukoencephalopathy, whereas others experience a progressive and irreversible course. Leukoencephalopathy is associated with neurobehavioral manifestations that may be subtle or devastating, and the syndrome of white matter dementia may …
Many patients have reversible leukoencephalopathy, whereas others experience a progressive and irreversible course. Leukoencephalopathy is a …
Behavioral effects of organophosphate in man.
Levin HS, Rodnitzky RL. Levin HS, et al. Clin Toxicol. 1976;9(3):391-403. doi: 10.3109/15563657608988138. Clin Toxicol. 1976. PMID: 782776 Review.
Clinical reports and laboratory investigations have generally supported the assumption that neurobehavioral manifestations of organophosphate toxicity are attributable to accumulation of acetylcholine at central and peripheral synapses as a result of cholinesterase …
Clinical reports and laboratory investigations have generally supported the assumption that neurobehavioral manifestations of …
81 results